unknown
Stage
About
Clyde Biosciences is a Glasgow-based contract research organization that provides in vitro cardiomyocyte assays using its CellOPTIQ® platform to measure electrophysiology, calcium dynamics, and contractility in human iPSC-derived cardiomyocytes. The company delivers cardiac safety and drug discovery services aligned with regulatory CiPA guidance to pharmaceutical and biotech clients.
Explore Clyde Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.